NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018

Authors :: Gregory P. Kalemkerian
Billy W. Loo
Wallace Akerley
Albert Attia
Michael Bassetti
Yanis Boumber
Roy Decker
M. Chris Dobelbower
Afshin Dowlati
Robert J. Downey
Charles Florsheim
Apar Kishor P. Ganti
John C. Grecula
Matthew A. Gubens
Christine L. Hann
James A. Hayman
Rebecca Suk Heist
Marianna Koczywas
Robert E. Merritt
Nisha Mohindra
Julian Molina
Cesar A. Moran
Daniel Morgensztern
Saraswati Pokharel
David C. Portnoy
Deborah Rhodes
Chad Rusthoven
Jacob Sands
Rafael Santana-Davila
Charles C. Williams
Karin G. Hoffmann
Miranda Hughes
Source :: Journal of the National Comprehensive Cancer Network. 16:1171-1182
Publication Year :: 2018
Publisher :: Harborside Press, LLC, 2018.
Abstract: The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."

Subjects :: 0301 basic medicine
medicine.medical_specialty
Lung Neoplasms
medicine.medical_treatment
Signs and symptoms
Medical Oncology
Systemic therapy
03 medical and health sciences
Antineoplastic Agents, Immunological
0302 clinical medicine
Antineoplastic Combined Chemotherapy Protocols
medicine
Humans
Disease management (health)
Pneumonectomy
Intensive care medicine
neoplasms
Societies, Medical
Neoplasm Staging
Randomized Controlled Trials as Topic
Brain Neoplasms
business.industry
Dose-Response Relationship, Radiation
Radiotherapy Dosage
Chemoradiotherapy
Immunotherapy
Small Cell Lung Carcinoma
Survival Analysis
United States
humanities
respiratory tract diseases
Radiation therapy
Treatment Outcome
030104 developmental biology
Oncology
030220 oncology & carcinogenesis
Non small cell
Cranial Irradiation
business

Full Text Access

Tools